EquityBulls

Latest News

Rail Vikas Nigam Ltd receives LoA from NMDC Ltd
Avantel Ltd receives additional order from Bharat Electronics Ltd
Venus Remedies receives Saudi FDA approval for Plerixafor - its first Marketing Authorization for the specialty oncology therapy globally
Kesar Infraventures Pvt Ltd secures EPC contract worth Rs. 160 crores
SPML Infra Wins Rs. 165.4 Crore Order to Build 400 kV Grid Sub-Station at Kota, Rajasthan

Keywords Selected: APY

Stock Report

Dr. Reddy's forays into Hormone Replacement Therapy segment with acquisition of Progynova® and Cyclo- Progynova® in India
Emcure expands weight management therapy access with Launch of Poviztra®
Aptus Pharma Ltd enters into Urology therapy segment
Regional Rural Banks, Bandhan Bank from Kolkata leads in pension funds subscribers
Jubilant Pharmova announces completion of USFDA audit of facility Located at Spokane, Washington, USA
EaseMyTrip unveils the Leap Year Travel Sale with unprecedented discounts on travel bookings
Venus Remedies consolidates in ASEAN, gets marketing approval for six chemotherapy drugs from the Philippines
Laurus Labs signs MOA with IIT Kanpur for novel gene therapy assets
Supriya Lifescience Limited receives CEP from EDQM for API
BridgeBio Pharma and Sentynl Therapeutics Receive Marketing Authorization in the EU for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A
Gufic Biosciences enters into research collaboration with Selvax Pty Ltd
Laurus Labs acquires substantial minority stake in a CAR-T cell therapy company - ImmunoACT